Subsequently, the cells were treated with 740Y-P, a highly selective activator of PI3K, and partial reversal of the inhibitory effects of RILP on the proliferation, migration, and invasion of osteosarcoma cells, were observed (Additional file 1: Fig. S1A–F). This evidence concerns the gene RILP and osteosarcoma.